Patents by Inventor Harshal Jahagirdar

Harshal Jahagirdar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified release formulation of lacosamide
    Patent number: 11278502
    Abstract: The present invention provides a modified release formulation of lacosamide. The modified release formulation of the present invention comprising lacosamide and modified release polymer provides modified release of lacosamide with minimal Cmax to Cmin peak to trough variation over a period of at least 12 hrs.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: March 22, 2022
    Assignee: LUPIN LIMITED
    Inventors: Shirishkumar Kulkarni, Satish Kumar Dalal, Harshal Jahagirdar, Kishore Kumar Konda
  • Modified release formulation of lacosamide
    Patent number: 10786464
    Abstract: The present invention provides a modified release formulation of lacosamide. The modified release formulation of the present invention comprising lacosamide and modified release polymer provides modified release of lacosamide with minimal Cmax to Cmin peak to trough variation over a period of at least 12 hrs.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: September 29, 2020
    Assignee: LUPIN LIMITED
    Inventors: Shirishkumar Kulkarni, Satish Kumar Dalal, Harshal Jahagirdar, Kishore Kumar Konda
  • PHARMACEUTICAL COMPOSITION OF NILOTINIB
    Publication number: 20200163962
    Abstract: A method of treating leukaemia comprising orally administering to a patient in need thereof reduced daily doses of nilotinib of 100 mg to 600 mg, wherein the nilotinib is administered in a dosage form having a composition comprising nilotinib butanedisulphonate (2:1) or nilotinib butanedisulphonate (1:1).
    Type: Application
    Filed: March 17, 2017
    Publication date: May 28, 2020
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Harshal JAHAGIRDAR, Bhushan JADHAV, Amol KULKARNI, Shirish KULKARNI, Rajamannar THENNATI
  • MODIFIED RELEASE FORMULATION OF LACOSAMIDE
    Publication number: 20190029968
    Abstract: The present invention provides a modified release formulation of lacosamide. The modified release formulation of the present invention comprising lacosamide and modified release polymer provides modified release of lacosamide with minimal Cmax to Cmin peak to trough variation over a period of at least 12 hrs.
    Type: Application
    Filed: September 28, 2018
    Publication date: January 31, 2019
    Applicant: LUPIN LIMITED
    Inventors: Shirishkumar Kulkarni, Satish Kumar Dalal, Harshal Jahagirdar, Kishore Kumar Konda
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR
    Publication number: 20140010883
    Abstract: The present invention provides a controlled release pharmaceutical composition comprising selective serotonin reuptake inhibitor and a process for preparation thereof. The controlled release pharmaceutical composition comprises: a deposit-core comprising a selective serotonin reuptake inhibitor, one or more controlled release agent(s) and one or more pharmaceutically acceptable excipient(s), a support-platform applied to the deposit-core, a controlled release coating and, an immediate release coating comprising a selective serotonin reuptake inhibitor and one or more pharmaceutically acceptable excipient(s).
    Type: Application
    Filed: March 16, 2012
    Publication date: January 9, 2014
    Applicant: LUPIN LIMITED
    Inventors: Harshal Jahagirdar, Ganesh Katkar, Satish Kumar Dalal, Shirishkumar Kulkarni
  • MODIFIED RELEASE FORMULATION OF LACOSAMIDE
    Publication number: 20120219631
    Abstract: The present invention provides a modified release formulation of lacosamide. The modified release formulation of the present invention comprising lacosamide and modified release polymer provides modified release of lacosamide with minimal Cmax to Cmin peak to trough variation over a period of at least 12 hrs.
    Type: Application
    Filed: November 3, 2010
    Publication date: August 30, 2012
    Applicant: LUPIN LIMITED
    Inventors: Shirishkumar Kulkarni, Satish Kumar Dalal, Harshal Jahagirdar, Kishore Kumar Konda
  • ANTIEMETIC-ORAL CONTRACEPTIVE COMBINATION
    Publication number: 20100240626
    Abstract: The present invention relates to a method of reducing the incidence of nausea and vomiting associated with the administration of oral contraceptive formulation and a method of preparation of oral contraceptive formulation comprising progestin and/or estrogen and an antiemetic. The preferred oral contraceptive formulation comprises of levonorgestrel and an antiemetic.
    Type: Application
    Filed: October 24, 2008
    Publication date: September 23, 2010
    Applicant: Lupin Limited
    Inventors: Sheetal Kulkarni, Srirupa Das, Harshal Jahagirdar, Satish Dalal, Shirish Kulkarni